Pfizer stated that the drug candidate, which is being evaluated for non-small cell lung cancer, metastatic colorectal cancer ...

Most pharmaceutical patents have their roots in work done or ... "If you want to shut down research, this will do it, and it will go first at places like the University of Tennessee and the University ...

Policy aims to drive drug companies to lower prices domestically while other countries shoulder more of the cost.

Qilu Pharmaceutical is paying 280 million Chinese yuan ($38 million) for a licensing and collaboration deal with fellow China biopharma Minghui Pharmaceutical. The pact centers on MHB088C ...

Mechanism for accelerating MNCs’ product launch in China The 2025 Draft provides for a mechanism designed to encourage pharmaceutical companies to accelerate the product launch and market entry ...

According to Piergiuseppe Fortunato, an adjunct professor of economics at the University ... of US imports from China in 2022. The US also imports a lot of its clothing and pharmaceutical product ...

Africa’s pharmaceutical ... Finally, China’s expertise in modernising Chinese traditional medicine presents an opportunity for African countries to develop their own traditional medicines.

Once a world leader in pharmaceutical manufacturing, the U.S. now relies heavily on drugs from overseas, increasingly from China. But that won’t be an option much longer. As President Trump ...

Company Logo Dublin, April 15, 2025 (GLOBE NEWSWIRE) -- The "China Pharmaceutical Directory 2025" has been added to ResearchAndMarkets.com's offering. The Chinese pharmaceutical industry has ...

Vietnam National University, Hanoi (VNU) and Tsinghua University (China) have signed a memorandum of understanding to establish the "Vietnam - China University Network," coinciding with the state ...

You have full access to this article via your institution. Over the past two decades, China’s pharmaceutical industry has benefited from an influx of experienced executives returning from ...

The revenue of China Resources Pharmaceutical Group grew at a compounded annual growth rate of 9.0% over the past 10 years. The growth is driven by its medical distribution segment due to industry ...